Check Inovio Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$115.9M
EPS (TTM)
-2.054
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-1.56
Industry PE ratio
-4.2220604395604395
P/B Ratio
0PEG Ratio
0EBITDA
-94.3M
Revenue (TTM)
182.3K
Profit Margin
0.00%
Return On Equity TTM
1869500.00%
Track how Inovio Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.
Inovio Pharmaceuticals, Inc. in the last 5 years
Lowest (0.00x)
September 18, 2025
Industry (-4.22x)
September 18, 2025
Today (-1.56x)
September 18, 2025
Highest (-0.63x)
March 31, 2025
Today’s Price to Earnings Ratio: -1.56x
Compare market cap, revenue, PE, and other key metrics of Inovio Pharmaceuticals, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $115.9M | -98.93% | -1.56 | 0.00% | |
BUY | $60.5B | 241.54% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $99.3B | 45.88% | 27.56 | 31.86% | |
BUY | $60.9B | 5.45% | 14.49 | 31.37% |
The Inovio Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Inovio Pharmaceuticals, Inc. investment value today
Current value as on today
₹37,006
Returns
Returns from Inovio Pharmaceuticals, Inc. Stock
Dollar Returns*
₹4,953 (+4.95%)
Based on 9 analysts
55.56%
Buy
44.44%
Hold
0.00%
Sell
Based on 9 analysts, 55.56% of analysts recommend a 'BUY' rating for Inovio Pharmaceuticals, Inc.. Average target price of $7.47
Get share price movements and forecasts by analysts on Inovio Pharmaceuticals, Inc..
What analysts predicted
70.95%UPSIDE
Target Price
$7.47
Current Price
$2.17
Analyzed by
9 Analysts
Target
$7.47
Inovio Pharmaceuticals, Inc. target price $7.47, a slight upside of 70.95% compared to current price of $2.17. According to 9 analysts rating.
Search interest for Inovio Pharmaceuticals, Inc. Stock has decreased by -10% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 202.1%
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 136.2%
Profit Down
Netprofit is down for the last 3 quarters, -19.38M → -23.51M (in $), with an average decrease of 10.5% per quarter
Price Dip
In the last 7 days, INO stock has moved down by -17.7%
Revenue Fall
Revenue is down for the last 2 quarters, 116.99K → 65.34K (in $), with an average decrease of 44.2% per quarter
Organisation | Inovio Pharmaceuticals, Inc. |
Headquarters | 660 West Germantown Pike, Plymouth Meeting, PA, United States, 19462 |
Industry | Health Technology |
CEO | Dr. Jacqueline E. Shea Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Robert L. Crotty J.D. | General Counsel, Corporate Secretary & Chief Compliance Officer |
Mr. E. J. Brandreth MBA | Senior Vice President of Quality Assurance |
Dr. Jeffrey Skolnik | Senior Vice President of Clinical Development |
Dr. Jacqueline E. Shea Ph.D. | CEO, President & Director |
Mr. Peter D. Kies | Chief Financial Officer |
Thomas Hong | Manager of Investor Relations |
Mr. Robert J. Juba Jr. | Senior Vice President of Biological Manufacturing & Clinical Supply Management |
Mr. Shawn D. Bridy M.A., M.B.A. | Senior Vice President of Business Development |
Dr. Michael Sumner M.D. | Chief Medical Officer |
Dr. Laurent M. Humeau Ph.D. | Chief Scientific Officer & Chairman of the Scientific Advisory Board |
Inovio Pharmaceuticals, Inc. share price today is $2.17 as on at the close of the market. Inovio Pharmaceuticals, Inc. share today touched a day high of $2.32 and a low of $2.16.
Inovio Pharmaceuticals, Inc. share touched a 52 week high of $7 on and a 52 week low of $1.3 on . Inovio Pharmaceuticals, Inc. stock price today i.e. is closed at $2.17,which is 69.00% down from its 52 week high and 66.92% up from its 52 week low.
Inovio Pharmaceuticals, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Inovio Pharmaceuticals, Inc. (INO) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Inovio Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Inovio Pharmaceuticals, Inc. share’s latest price of $2.17 as on September 18, 2025 at 1:29 am IST, you will get 4.6083 shares of Inovio Pharmaceuticals, Inc.. Learn more about
fractional shares .
Inovio Pharmaceuticals, Inc. stock has given -98.93% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?